Oncolytics Biotech Inc.
ONCY
$0.80
-$0.01-1.24%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -78.93% | -96.20% | -40.40% | -49.43% | 0.48% |
| Total Depreciation and Amortization | -16.67% | -15.79% | 1.79% | -12.34% | -74.86% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 59.68% | 339.97% | 408.14% | 1,630.76% | 1,643.93% |
| Change in Net Operating Assets | -188.99% | -57.68% | 112.09% | -40.62% | -371.80% |
| Cash from Operations | -98.20% | -54.09% | 0.95% | -36.31% | 17.60% |
| Capital Expenditure | -- | -500.00% | 92.56% | 78.30% | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -500.00% | 92.56% | 78.30% | 100.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | 29.47% | -26.25% | -- |
| Issuance of Common Stock | 65.16% | 81.67% | 16.64% | 1,444.60% | 81.94% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 71.53% | -71.53% | -64.08% | 48.95% | 209.92% |
| Cash from Financing | 65.39% | 82.02% | 5.52% | 2,469.40% | 183.66% |
| Foreign Exchange rate Adjustments | -112.50% | -120.51% | 148.03% | 213.32% | -51.06% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1,913.16% | 167.05% | 30.29% | 57.12% | 102.19% |